Mesa Laboratories Inc. (MLAB)
Mesa Laboratories Statistics
Share Statistics
Mesa Laboratories has 5.43M shares outstanding. The number of shares has increased by 0.73% in one year.
| Shares Outstanding | 5.43M |
| Shares Change (YoY) | 0.73% |
| Shares Change (QoQ) | 0.04% |
| Owned by Institutions (%) | 94.01% |
| Shares Floating | 5.23M |
| Failed to Deliver (FTD) Shares | 368 |
| FTD / Avg. Volume | 0.94% |
Short Selling Information
The latest short interest is 190.23K, so 3.5% of the outstanding shares have been sold short.
| Short Interest | 190.23K |
| Short % of Shares Out | 3.5% |
| Short % of Float | 3.65% |
| Short Ratio (days to cover) | 4.68 |
Valuation Ratios
The PE ratio is -2.37 and the forward PE ratio is 20.25. Mesa Laboratories's PEG ratio is 0.
| PE Ratio | -2.37 |
| Forward PE | 20.25 |
| PS Ratio | 2.79 |
| Forward PS | 2.5 |
| PB Ratio | 4.15 |
| P/FCF Ratio | 14.51 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Mesa Laboratories.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.47, with a Debt / Equity ratio of 1.59.
| Current Ratio | 2.47 |
| Quick Ratio | 1.73 |
| Debt / Equity | 1.59 |
| Debt / EBITDA | -0.97 |
| Debt / FCF | 5.56 |
| Interest Coverage | -47.76 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $293.73K |
| Profits Per Employee | $-345.44K |
| Employee Count | 736 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 2.54 |
Taxes
| Income Tax | -21.4M |
| Effective Tax Rate | 7.76% |
Stock Price Statistics
The stock price has increased by 21.78% in the last 52 weeks. The beta is 0.82, so Mesa Laboratories's price volatility has been higher than the market average.
| Beta | 0.82 |
| 52-Week Price Change | 21.78% |
| 50-Day Moving Average | 135.32 |
| 200-Day Moving Average | 123.5 |
| Relative Strength Index (RSI) | 40.47 |
| Average Volume (20 Days) | 39.27K |
Income Statement
In the last 12 months, Mesa Laboratories had revenue of 216.19M and earned -254.25M in profits. Earnings per share was -47.2.
| Revenue | 216.19M |
| Gross Profit | 133.25M |
| Operating Income | -272.07M |
| Net Income | -254.25M |
| EBITDA | -238.38M |
| EBIT | -269.95M |
| Earnings Per Share (EPS) | -47.2 |
Balance Sheet
The company has 28.21M in cash and 231.3M in debt, giving a net cash position of -203.08M.
| Cash & Cash Equivalents | 28.21M |
| Total Debt | 231.3M |
| Net Cash | -203.08M |
| Retained Earnings | -183.49M |
| Total Assets | 437.15M |
| Working Capital | -45.03M |
Cash Flow
In the last 12 months, operating cash flow was 44.13M and capital expenditures -2.57M, giving a free cash flow of 41.57M.
| Operating Cash Flow | 44.13M |
| Capital Expenditures | -2.57M |
| Free Cash Flow | 41.57M |
| FCF Per Share | 7.72 |
Margins
Gross margin is 61.64%, with operating and profit margins of -125.85% and -117.6%.
| Gross Margin | 61.64% |
| Operating Margin | -125.85% |
| Pretax Margin | -127.5% |
| Profit Margin | -117.6% |
| EBITDA Margin | -110.26% |
| EBIT Margin | -125.85% |
| FCF Margin | 19.23% |
Dividends & Yields
MLAB pays an annual dividend of $0.8, which amounts to a dividend yield of 0.46%.
| Dividend Per Share | $0.80 |
| Dividend Yield | 0.46% |
| Dividend Growth (YoY) | 0% |
| Payout Ratio | -1.73% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for MLAB is $140, which is 15.2% higher than the current price. The consensus rating is "Hold".
| Price Target | $140 |
| Price Target Difference | 15.2% |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
Scores
| Altman Z-Score | -0.76 |
| Piotroski F-Score | 5 |